AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sagimet Biosciences Inc.

$9.92 +$3.93 (+65.61%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$10.43
Day Range
$9.82$10.51
Year Range
$4.50$11.45
Market Cap
323.21M
AVG Volume
1.32M
Trailing/Forward PE
-7.75/-
PEG ratio
0.24
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD) · A
0500K1M1.5M2M2022202320242025
SGMT Revenue (USD) by year
PeriodRevenue (USD)
20250
20240
20232M
20220
Net Income (USD) · A
-60M-40M-20M02022202320242025
SGMT Net Income (USD) by year
PeriodNet Income (USD)
2025-51.04M
2024-45.57M
2023-27.88M
2022-30.5M
Operating Income (USD) · A
-60M-40M-20M02022202320242025
SGMT Operating Income (USD) by year
PeriodOperating Income (USD)
2025-56.89M
2024-54.45M
2023-30.74M
2022-31.05M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: SGMT

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

Sagimet Biosciences Inc.
SGMT
Stockpicker

Video analysis: SGMT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SGMT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.